Vector Science & Therapeutics (the "Company") today announced the filing of a provisional patent application covering a novel catheter-based platform designed for intratumoral drug delivery research, ...

Led by a team of Cornell faculty, the Northeast Regional Center for Excellence in Vector-Borne Diseases received a five-year, $8.7 million grant from the Centers for Disease Control and Prevention in ...

The AAV vector manufacturing market is mainly fueled by the expanding landscape of gene therapy research and development, as AAV vectors are extensively utilized for therapeutic gene delivery because ...

This project builds on recent work reporting tick transmission of relapsing fever spirochetes and genome sequencing of both the pathogen and tick vector. We have utilized both next generation and ...

Lentiviruses have the unique ability amongst retroviruses of being able to infect non-cycling cells. Vectors derived from lentiviruses have provided a huge advancement in technology and seemingly ...

The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides ...

Vector Research is a privately held, high-end analysis and IT services firm with 350 employees in Ann Arbor, northern Virginia and San Antonio. Vector develops information systems and decision models ...

The global lentiviral vector CDMO market is projected to grow at a CAGR of 8% over the next five years. This growth is driven by rising demand for gene and cell therapies, an expanding pipeline of ...

A study on vector database and AI integration identifies unstable indexing, weak cross-modal fusion, and rigid resource ...